|
Rivex Pharma Inc is the drug distribution division
of Helix. The company has its own drug registrations
and acts as Canadian distributor for a variety of European
and American pharmaceutical companies. Rivex also provides
Regulatory and Clinical services for these companies
as well as a full complement of Sales, Marketing and
Logistics activities.
Gastroenterology is a key therapeutic area for the
company with products for bowel lavage as well as a natural bulk
forming laxative. The area of Immunology presents unique
opportunities for Rivex as there is increasing focus
on immunomodulatory drugs as a possible way to treat
immune based diseases such as Chronic Fatigue Syndrome
and Fibromyalgia. These therapeutic segments offer an
ideal niche opportunity for the company to promote its
products.
Osteoarthritis is another major focus for Rivex. It is estimated that greater than 5% of the
world's population is affected by osteoarthritis of
the knee. Conventional treatment methods such as
weight loss, pain medication, and intra-articular
steroids simply mask the pain caused by osteoarthritis.
ORTHOVISC® and now MONOVISC™ represent safe, convenient, nonsurgical treatmentS for osteoarthritis
that not only reduces pain but also may prevent further damage.
Our Partners
Rivex’s partners include:
Anika Therapeutics Inc.: www.Anikatherapeutics.com
Norgine Pharma Inc: www.norgine.com
Helsinn Birex Pharmaceuticals: www.helsinn.com
Newport Pharmaceuticals: www.newportpharmaceuticals.com
| 
